Home

About Us

Resources

Services

Contact Us

Tags | publications

Home » publications » Page 2

hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma

hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma

Emergence of a mutation in the nucleocapsid gene of SARS-CoV-2 interferes with PCR detection in Canada

Emergence of a mutation in the nucleocapsid gene of SARS-CoV-2 interferes with PCR detection in Canada

Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis

Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis

Early signatures of breast cancer up to seven years prior to clinical diagnosis in plasma cell-free DNA methylomes

Early signatures of breast cancer up to seven years prior to clinical diagnosis in plasma cell-free DNA methylomes

DNA Methylation-Based Classification of Small B-Cell Lymphomas: A Proof-of-Principle Study

DNA Methylation-Based Classification of Small B-Cell Lymphomas: A Proof-of-Principle Study

The telomere length landscape of prostate cancer

The telomere length landscape of prostate cancer

Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data

Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data

Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study

Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study

Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature

Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity

1 2 3